• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Immunohistochemical distinction of malignant mesothelioma from pulmonary adenocarcinoma with anti-surfactant apoprotein, anti-Lewisa, and anti-Tn antibodies.

作者信息

Noguchi M, Nakajima T, Hirohashi S, Akiba T, Shimosato Y

机构信息

Pathology Division, National Cancer Center Research Institute, Tokyo, Japan.

出版信息

Hum Pathol. 1989 Jan;20(1):53-7. doi: 10.1016/0046-8177(89)90202-5.

DOI:10.1016/0046-8177(89)90202-5
PMID:2912874
Abstract

Nine cases of malignant mesothelioma of pure epithelial and biphasic types (five pleural, three peritoneal, and one pericardial mesotheliomas), seven cases of benign adenomatoid tumor of the uterus, and 21 cases of peripheral pulmonary adenocarcinoma of non-mucus-producing type were examined immunohistochemically for expression of keratin, vimentin, carcinoembryonic antigen (CEA), surfactant apoprotein, Lewis blood group antigens, and Tn antigen. The majority (78%) of the malignant mesotheliomas expressed keratin, but CEA and surfactant apoprotein were not detected in any mesotheliomas. On the other hand, pulmonary adenocarcinomas expressed not only keratin (100%), but also CEA (62%) and surfactant apoprotein (62%). The expression of Lewisa blood group antigen and Tn antigen was detected in 76% and 62% of the pulmonary adenocarcinomas, respectively, but only one mesothelioma was stained for Lewisa antigen. This study reveals that the majority of malignant mesotheliomas can be distinguished from pulmonary adenocarcinomas by immunohistochemcial staining for CEA, surfactant apoprotein, Lewisa antigen, and Tn antigen. Immunohistochemically, adenomatoid tumors behaved similarly to malignant mesotheliomas.

摘要

相似文献

1
Immunohistochemical distinction of malignant mesothelioma from pulmonary adenocarcinoma with anti-surfactant apoprotein, anti-Lewisa, and anti-Tn antibodies.
Hum Pathol. 1989 Jan;20(1):53-7. doi: 10.1016/0046-8177(89)90202-5.
2
Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma.角蛋白和癌胚抗原免疫组化染色在恶性间皮瘤诊断中的应用
Am J Surg Pathol. 1984 Apr;8(4):277-9. doi: 10.1097/00000478-198404000-00004.
3
Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.免疫组织化学在恶性间皮瘤与肺腺癌鉴别诊断中的应用:对新型抗体的批判性评估
J Clin Pathol. 2002 Sep;55(9):662-8. doi: 10.1136/jcp.55.9.662.
4
The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.间皮瘤的免疫组化诊断。间皮瘤与肺腺癌的鉴别。
Am J Surg Pathol. 1989 Apr;13(4):276-91.
5
Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma.肺腺癌和恶性间皮瘤所致胸腔积液中的肺表面活性物质蛋白-A和癌胚抗原
Eur Respir J. 1995 Mar;8(3):403-6. doi: 10.1183/09031936.95.08030403.
6
Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach.
Cancer. 1985 Apr 15;55(8):1679-85. doi: 10.1002/1097-0142(19850415)55:8<1679::aid-cncr2820550812>3.0.co;2-c.
7
Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.恶性间皮瘤。使用单克隆抗体44 - 3A6和624A12改善与肺腺癌的鉴别诊断。
Am J Pathol. 1986 Jun;123(3):497-507.
8
Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.钙视网膜蛋白、血栓调节蛋白、癌胚抗原和CD15:用于鉴别胸膜上皮性间皮瘤与周围型肺腺癌的一组有用的免疫组化标志物。
Hum Pathol. 2001 May;32(5):529-36. doi: 10.1053/hupa.2001.24329.
9
Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.恶性间皮瘤和肺腺癌的抗原表型。一项免疫组织学分析证明了Leu M1抗原的价值。
Am J Pathol. 1986 May;123(2):212-9.
10
Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.恶性间皮瘤:免疫组织化学和DNA倍体分析作为鉴别胸膜和腹膜积液中间皮瘤与良性反应性间皮细胞增生及腺癌的方法。
Arch Pathol Lab Med. 1996 Oct;120(10):959-66.

引用本文的文献

1
The Role of Pulmonary Collectins, Surfactant Protein A (SP-A) and Surfactant Protein D (SP-D) in Cancer.肺凝集素、表面活性蛋白A(SP-A)和表面活性蛋白D(SP-D)在癌症中的作用
Cancers (Basel). 2024 Sep 10;16(18):3116. doi: 10.3390/cancers16183116.
2
Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.癌症中的蛋白质糖基化及其在神经母细胞瘤中的潜在治疗应用。
J Hematol Oncol. 2016 Sep 29;9(1):100. doi: 10.1186/s13045-016-0334-6.
3
Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett's esophagus.
比较六种免疫组织化学标志物在 Barrett 食管肿瘤组织学诊断中的应用。
Virchows Arch. 2010 Nov;457(5):537-45. doi: 10.1007/s00428-010-0972-y. Epub 2010 Sep 16.
4
The classification of pericardial disease in the age of modern medicine.现代医学时代的心包疾病分类。
Curr Cardiol Rep. 2002 Jan;4(1):13-21. doi: 10.1007/s11886-002-0121-6.
5
Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findings.石蜡包埋组织中鉴别胸膜间皮瘤和肺腺癌的诊断工具。第一部分:免疫组化结果。
Virchows Arch A Pathol Anat Histopathol. 1993;423(1):19-27. doi: 10.1007/BF01606427.
6
Primary malignant mesothelioma of the pericardium. Case report and literature review.原发性心包恶性间皮瘤。病例报告及文献复习。
Tex Heart Inst J. 1994;21(2):170-4.
7
ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.ME1. 一种可区分上皮型恶性间皮瘤与肺腺癌及肺外恶性肿瘤的单克隆抗体。
Am J Pathol. 1990 Feb;136(2):421-8.